Is there a rationale for neuroprotection against dopamine toxicity in Parkinson's disease?

被引:69
作者
Barzilai, A [1 ]
Melamed, E
Shirvan, A
机构
[1] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiochem, IL-69978 Tel Aviv, Israel
[2] Rabin Med Ctr, Dept Neurol, Tel Aviv, Israel
[3] Rabin Med Ctr, Felsenstein Med Res Inst, Tel Aviv, Israel
[4] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel
关键词
dopamine; L-DOPA; Parkinson's disease; oxidative stress; semaphorins; apoptosis;
D O I
10.1023/A:1010991020245
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Parkinson's disease is a progressive neurological disease caused by rather selective degeneration of the dopaminergic neurons in the substantia nigra. Though subject to intensive research, the etiology of this nigral loss is still undetermined and treatment is basically symptomatic. The current major hypothesis is that nigral neuronal death in PD is due to excessive oxidative stress generated by auto and enzymatic oxidation of the endogenous neurotransmitter dopamine (DA), the formation of neuromelanin (MM) and the presence of a high concentration of iron. In this review article although we concisely describe the effects of NM and iron on neuronal survival, we mainly focus on the molecular mechanisms of DA-induced apoptosis, DA exerts its toxic effects through its oxidative metabolites either in vitro or in vivo The oxidative metabolites then activate a very intricate web of signals, which culminate in cell death. The signal transduction pathways and genes, which are associated with DA toxicity are described in detail.
引用
收藏
页码:215 / 235
页数:21
相关论文
共 125 条
[1]   A novel class of murine semaphorins with homology to thrombospondin is differentially expressed during early embryogenesis [J].
Adams, RH ;
Betz, H ;
Puschel, AW .
MECHANISMS OF DEVELOPMENT, 1996, 57 (01) :33-45
[2]   IRON MELANIN INTERACTION AND LIPID-PEROXIDATION - IMPLICATIONS FOR PARKINSONS-DISEASE [J].
BENSHACHAR, D ;
RIEDERER, P ;
YOUDIM, MBH .
JOURNAL OF NEUROCHEMISTRY, 1991, 57 (05) :1609-1614
[3]   DOPAMINE NEUROTOXICITY - INHIBITION OF MITOCHONDRIAL RESPIRATION [J].
BENSHACHAR, D ;
ZUK, R ;
GLINKA, Y .
JOURNAL OF NEUROCHEMISTRY, 1995, 64 (02) :718-723
[4]   Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: Implications for Parkinson's disease [J].
Berman, SB ;
Hastings, TG .
JOURNAL OF NEUROCHEMISTRY, 1999, 73 (03) :1127-1137
[5]   p53 and Bax activation in 6-hydroxydopamine-induced apoptosis in PC12 cells [J].
Blum, D ;
Wu, Y ;
Nissou, MF ;
Arnaud, S ;
Benabid, AL ;
Verna, JM .
BRAIN RESEARCH, 1997, 751 (01) :139-142
[6]   MPP+-induced mitochondrial dysfunction is potentiated by dopamine [J].
Boada, J ;
Cutillas, B ;
Roig, T ;
Bermúdez, J ;
Ambrosio, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 268 (03) :916-920
[7]  
BRESDESEN DJ, 1995, ANN NEUROL, V38, P839
[8]  
Cadet JL, 2000, SYNAPSE, V35, P228
[9]   Neuropilin-2, a novel member of the neuropilin family, is a high affinity receptor for the semaphorins Sema E and Sema IV but not Sema III [J].
Chen, H ;
Chedotal, A ;
He, ZG ;
Goodman, CS ;
TessierLavigne, M .
NEURON, 1997, 19 (03) :547-559
[10]   Differential neurotoxicity induced by L-DOPA and dopamine in cultured striatal neurons [J].
Cheng, NN ;
Maeda, T ;
Kume, T ;
Kaneko, S ;
Kochiyama, H ;
Akaike, A ;
Goshima, Y ;
Misu, Y .
BRAIN RESEARCH, 1996, 743 (1-2) :278-283